摘要 |
<p>The invention provides isolated nucleic acids that encode a human Ras interacting protein (RasIn), including a shorter isoform (RasInS), and fragments thereof, vectors for propagating and expressing RasIn nucleic acids, host cells comprising the nucleic acids and vectors of the present invention, proteins, protein fragments, and protein fusions of the novel RasIn isoforms, and antibodies thereto. The invention further provides transgenic cells and non-human organisms comprising human RasIn nucleic acids, and transgenic cells and non-human organisms with targeted disruption of the endogenous orthologue of the human RasIn gene. The invention further provides pharmaceutical formulations of the nucleic acids, proteins, and antibodies of the present invention, and diagnostic, investigational, and therapeutic methods based on the RasIn nucleic acids, proteins, and antibodies of the present invention.</p> |